rs142353672
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_017986.4(SLC52A1):c.1240G>A(p.Ala414Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000149 in 1,613,578 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017986.4 missense
Scores
Clinical Significance
Conservation
Publications
- maternal riboflavin deficiencyInheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: ClinGen, Orphanet, Ambry Genetics
- ariboflavinosisInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152182Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000759 AC: 19AN: 250406 AF XY: 0.0000739 show subpopulations
GnomAD4 exome AF: 0.000157 AC: 230AN: 1461396Hom.: 0 Cov.: 32 AF XY: 0.000173 AC XY: 126AN XY: 727008 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152182Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74344 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Uncertain:1
This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 414 of the SLC52A1 protein (p.Ala414Thr). This variant is present in population databases (rs142353672, gnomAD 0.01%). This missense change has been observed in individual(s) with sporadic early onset Parkinson disease (PMID: 23506902). ClinVar contains an entry for this variant (Variation ID: 583054). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SLC52A1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at